Big Buttons

• CALL TO ACTION: Tell FDA to deny drugmakers’ request

  Drugmakers are urging FDA to prohibit compounded GLP-1s. FDA needs to hear from you and your patients NOW! read more →

• APC to FDA: Just say no to Lilly

  This week APC's lawyers sent a formal comment to the FDA about Eli Lilly’s request that tirzepatide be added to the Demonstrably Difficult to Compound list. read more →

• California BOP sends proposed compounding regs to comment period

  The California State Board of Pharmacy decided to move the modified proposed sterile compounding regulations forward to a 30-day comment period. read more →

• Checking in on the post-Chevron fallout

  What’s happened in the world of federal regulation since the end of Chevron? read more →

• Hi, Noom!

  Welcome to our newest Bronze-level Corporate Patron, Noom! read more →

• PFMs can get 2.5% credit card processing

  A new benefit for APC’s Pharmacy/Facility Members: They may be able to cut their credit card processing fees to just 2.5% – 2.8%. read more →

• Phoenix compounders, rise!

  The latest of APC’s new regional meetings — CompoundED UpDATE — is coming to the Phoenix area December 5. read more →

• APC election results: directors and bylaws

  See the results of APC's elections, including four new directors and several changes to our bylaws. read more →

More News

With the passing of Dr. Loyd V. Allen, Jr., PhD, this week, our profession lost a giant.

No hyperbole here: His passion for and influence over the ethical practice of pharmacy compounding is simply unequalled. 

If you are a long-time compounder, he is surely known to you. If you are newer to our profession and he is not known to you, he should be. Read his full obituary here, but here’s the gist:

A visionary leader, Dr. Loyd Allen revolutionized the field of pharmaceutical compounding, spearheading groundbreaking research and innovation. His contributions extended far beyond the classroom, as he served as a consultant to compounding pharmacists and the pharmaceutical industry. His scholarly output included over 100 experimental publications, 30 books, chapters, and monographs, and the award-winning Editor-in Chief of the 22nd edition of Remington: The Science and Practice of Pharmacy.

And that’s not half of it. A couple of other bits worth mention: He was also the long-time editor-in-chief of the International Journal of Pharmacy Compounding. A longtime supporter of IACP and APC as well, three years ago he led our work group that revitalized and rebooted APC’s Compounder Code of Ethics. That document is a direct reflection of Allen’s own ethic and participation in his profession.

What a loss his death is – but what a life of service.

Dr. Allen was a man of faith. One couldn’t read his weekly Compounding Today e-newsletter without picking up on that fact (well that, and that he loved Burma Shavesigns). He lived a life of humble work in and to the communities he was a part of. His efforts to instill competence, care, and integrity in the practice of pharmacy compounding will continue to benefit patients for years to come. For all these reasons, allow me to borrow a bit of Christian scripture here and say: Well done, good and faithful servant.

To his family we extend our deepest sympathy. May he rest in peace.

— Joe

Joseph P. Navarra, RPh, FACA, FAPC is the owner of Town Total Compounding Center in Woodbury, New York. You can reach him at joseph.navarra@towntotalcompound.com.